Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Authors:
- Tobias LahmerTLTobias Lahmer
- Jon Salmanton-GarcíaJSJon Salmanton-García
- Francesco MarchesiFMFrancesco Marchesi
- Shaimaa El-AshwahSEShaimaa El-Ashwah
- Marcio NucciMNMarcio Nucci
- Caroline BessonCBCaroline Besson
- Federico ItriFIFederico Itri
- Ozren JaksicOJOzren Jaksic
- Natasha ČolovićNČNatasha Čolović
- Barbora WeinbergerováBWBarbora Weinbergerová
- Guldane Cengiz SevalGSGuldane Cengiz Seval
Open Access
- 22 February 2024
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 52 (3) , 1125-1141
Abstract
No abstract availableFunding Information
- Universitätsklinikum Köln
This publication has 44 references indexed in Scilit:
- Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with CancerCancer Discovery, 2021
- COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experienceJournal of Allergy and Clinical Immunology, 2021
- Intensive care management of patients with COVID-19: a practical approachAnnals of Intensive Care, 2021
- Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patientsBlood, 2020
- Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data HubBlood Advances, 2020
- Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort studyIntensive Care Medicine, 2020
- The outcome of COVID‐19 in patients with hematological malignancyJournal of Medical Virology, 2020
- Determinants of COVID-19 disease severity in patients with cancerNature Medicine, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020